NCT02422121View on ClinicalTrials.gov

Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Asthma
Interventions
DRUG

RNS60

DRUG

Placebo

Trial Locations (1)

Unknown

Quintiles Drug Research Unit at Guy's Hospital, London

All Listed Sponsors
lead

Revalesio Corporation

INDUSTRY

NCT02422121 - Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge | Biotech Hunter | Biotech Hunter